Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,570 | 9,130 | 9,088 | 18,817 | 12,821 |
| Marketable Securities | N/A | N/A | 1,578 | 1,615 | 1,841 |
| Receivables | 40 | 3,706 | 41 | 266 | 174 |
| TOTAL | $11,150 | $13,744 | $10,904 | $21,095 | $15,099 |
| Non-Current Assets | |||||
| PPE Net | 318 | 257 | 242 | 360 | 476 |
| TOTAL | $318 | $257 | $242 | $360 | $476 |
| Total Assets | $11,469 | $14,001 | $11,146 | $21,455 | $15,575 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,409 | 2,842 | 3,073 | 2,123 | 3,057 |
| Other current liabilities | 763 | 1,192 | N/A | N/A | N/A |
| TOTAL | $2,171 | $4,034 | $3,073 | $2,123 | $3,057 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,517 | 3,577 | 0 | 0 | 0 |
| TOTAL | $4,517 | $3,577 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,689 | $7,611 | $3,073 | $2,123 | $3,057 |
| Shareholders' Equity | |||||
| Common Shares | 220,026 | 209,597 | 198,105 | 204,748 | 215,294 |
| Retained earnings | -240,309 | -227,136 | -210,572 | -206,601 | -226,445 |
| Other shareholders' equity | 3,260 | 3,079 | 419 | 596 | 254 |
| TOTAL | $4,780 | $6,390 | $8,073 | $19,332 | $12,519 |
| Total Liabilities And Equity | $11,469 | $14,001 | $11,146 | $21,455 | $15,575 |